Skip to main content
SpringerLink
Log in

The diagnosis of renovascular hypertension: the role of captopril renal scintigraphy and related issues

  • Review Article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

This article reviews the screening and diagnostic tests used in the detection of significant renal artery stenosis and renovascular hypertension. After addressing the pathophysiological considerations necessary for correct diagnostic test interpretation, this review critically surveys the recent advances in, and the limitations of, relevant investigational procedures and in particular focusses on the efficacy and issues of Angotensin-converting enzyme inhibitor renal scintigraphy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Goldblatt H, Lynch J, Hanzal RE, Summerville WW. Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934;59:347–378.

    Google Scholar 

  2. Holley KE, Hunt JC, Brown AL, Kincaid OW, Sheps SG. Renal artery stenosis. A clinical-pathologic study in normotensive and hypertensive patients. Am J Med 1964;37:14–22.

    Google Scholar 

  3. Eyler WR, Clark MD, Garman JE, Rian RL, Meininger DE. Angiography of the renal areas including a comparative study of renal arterial stenoses in patients with and without hypertension. Radiology 1962;78:879–891.

    Google Scholar 

  4. Dustan HP, Humphries AW, De Wolf VG, Page IH. Normal pressure in patients with renal arterial stenosis. JAMA 1964;187:1028–1032.

    Google Scholar 

  5. Working Group on Renovascular Hypertension. Detection, evaluation and treatment of renovascular hypertension. Arch Intern Med 1987;147:820–829.

    Google Scholar 

  6. Davis BA, Crook JE, Vestal RE, Oates JA. Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy. N Engl J Med 1979;301:1273–1276.

    Google Scholar 

  7. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984;11:383–392

    Google Scholar 

  8. Ramsay LE, Waller PC. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. Br Med J 1990;300:569–572.

    Google Scholar 

  9. Kremer Hovinga TK, De Jong PE, Van Der Hem GK, De Zeeuw D. Relief of renal artery stenosis: a tool to improve or preserve renal function in renovascular disease? Nephrol Dial Transplant 1990;5:481–488.

    Google Scholar 

  10. Anderson WP, Woods RL. Intrarenal effects of angiotensin II in renal artery stenosis. Kidney Int 1987;31:S157-S167.

    Google Scholar 

  11. Levenson DJ, Dzau VJ. Effects of angiotensin-converting enzyme inhibition on renal hemodynamics in renal artery stenosis. Kidney Int 1987;31:S173-S179.

    Google Scholar 

  12. Pickering TG, Renovascular hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis and management. New York: Raven, 1990:1539–1559.

    Google Scholar 

  13. Martinez-Maldonado M. Pathophysiology of renovascular hypertension. Hypertension 1991;17:707–719.

    Google Scholar 

  14. Nally JV, Black HR. State of the art: captopril renography. Pathophysiological considerations and clinical observations. Semin Nucl Med 1992;22:85–97.

    Google Scholar 

  15. Jonker GJ, Visscher CA, De Zeeuw D, Huisman RM, Piers DA, Beckhuis H, Van Der Hem GK. Changes in renal function induced by ACE-inhibition in the conscious two-kidney, oneclip Goldblatt hypertensive dog. Nephron 1992;60:226–231.

    Google Scholar 

  16. Jacobson HR. Ischemic renal disease: an overlooked clinical entity? Kidney Int 1988;34:729–743.

    Google Scholar 

  17. Michel JB, Dussaule JC, Choudat L, Nochy D, Corvol P, Menard J. Renal damage induced in the clipped kidney of one-clip, two-kidney hypertensive rats during normalization of blood pressure by converting-enzyme inhibition. Kidney Int 1987;31:S168-S172.

    Google Scholar 

  18. Hughes JS, Dove HG, Gifford RW, Feinstein AR. Duration of blood pressure elevation in accurately predicting surgical cure of renovascular hypertension. Am Heart J 1981;101:408–413.

    Google Scholar 

  19. Nally JV Renal scintigraphy in the evaluation of renovascular hypertension: a note of optimism yet caution. J Nucl Med 1987;28:1501–1505.

    Google Scholar 

  20. Svetkey LP, Himmelstein SI, Dunnick NR, Wilkinson RH Jr, Bollinger RD, McCann RL, Beytas EM, Klotman PE. Prospective analysis of strategies for diagnosing renovascular hypertension. Hypertension 1989;14:247–257.

    Google Scholar 

  21. Kaplan NM. Renal vascular hypertension. In: Kaplan NM, ed. Clinical hypertension. Baltimore: Williams and Wilkins; 1990:303–324.

    Google Scholar 

  22. Havey RJ, Krumlovsky F, Del Greco F, Martin HG. Screening for renovascular hypertension. Is renal digital-subtraction angiography the preferred noninvasive test? JAMA 1985;254:388–393.

    Google Scholar 

  23. Wilms GE, Baert AL, Staessen JA, Amery AK. Renal artery stenosis: evaluation with intravenous digital subtraction angiography. Radiology 1986:160:713–715.

    Google Scholar 

  24. Illescas FF, Braun SD, Cohan RH, Sussman SK, Saeed M, Dunnick NR. Fibromuscular dysplasia of renal arteries: comparison of intravenous digital subtraction with conventional angiography. J Can Assoc Radiol 1988;39:167–171.

    Google Scholar 

  25. Distler A, Spies KP. Diagnosis procedure in renovascular hypertension. Clin Nephrol 1991;36:174–180.

    Google Scholar 

  26. Berland LL, Koslin DB, Routh WD, Keller FS. Renal artery stenosis: prospective evaluation of diagnosis with color Duplex US compared with angiography. Radiology 1990;174:421–423.

    CAS  PubMed  Google Scholar 

  27. Desberg AL, Paushter DM, Lammert GK, Hale JC, Troy RB, Novick AC, Nally JV, Weltevreden AM. Renal artery stenosis: evaluation with color Doppler flow imaging. Radiology 1990;177:749–753.

    CAS  PubMed  Google Scholar 

  28. Taylor KJW, Morse SS, Rigsby CM, Bia M, Schiff M. Vascular complications in renal allografts: detection with duplex Doppler US. Radiology 1987;162:31–38.

    Google Scholar 

  29. Glicklich D, Tellis VA, Quinn T, Mallis M, Greenstein SM, Schechner R, Heller S, Freeman LM, Kutcher R, Veith FJ. Comparison of captopril scan and Doppler ultrasonography as screening tests for transplant renal artery stenosis. Transplantation 1990;49:217–219.

    Google Scholar 

  30. Kim D, Edelman RR, Kent KC, Porter DH, Skillman JJ. Abdominal aorta and renal artery stenosis: evaluation with MR angiography. Radiology 1990;174:727–731.

    Google Scholar 

  31. Debatin JF, Spritzer CE, Grist TM, Beam C, Svetkey LP, Newman GE, Sostman HD. Imaging of the renal arteries: value of MR angiography. AJR 1991;157:981–990.

    Google Scholar 

  32. Rudnick MR, Maxwell MH. Diagnosis of renovascular hypertension: limitations of renin assays. In: Narins R, ed. Controversies in nephrology and hypertension. New York: Churchill-Livingstone; 1984:123–142.

    Google Scholar 

  33. Derkx FHM, Tan-tjiong LH, Wenting GJ, Man In't Veld A, Schalekamp MADH. Use of captopril in the diagnostic workup of renovascular hypertension. J Hypertens 1985;3 Suppl 3:287–289.

    Google Scholar 

  34. Muller FB, Sealey JE, Case DB, Atlas SA, Pickering TG, Pecker MS, Preibisz JJ, Laragh JH. The captopril test for identifying renovascular disease in hypertensive patients. Am J Med 1986;80:633–644.

    Google Scholar 

  35. Idrissi A, Fournier A, Renaud H, Boudailliez B, El Esper N, Fievet P, Westeel PF, Makdassi R, Remond A. The captopril challenge test as a screening test for renovascular hypertension. Kidney Int 1988;34:S138-S141.

    Google Scholar 

  36. Erley CM, Risler T. Failure of the captopril test to identify renovascular disease in young hypertensive patients. Nephron 1991;57:123–124.

    Google Scholar 

  37. Thornbury JR, Stanley JC, Fryback DG. Hypertensive urogram: a nondiscriminatory test for renovascular hypertension. AJR 1982;138:43–49.

    Google Scholar 

  38. Pickering TG, Sos TA, Vaughan ED, Case DB, Sealey JE, Harshfield GA, Laragh JH. Predictive value and changes of renin secretion in hypertensive patients with unilateral renovascular disease undergoing successful renal angioplasty. Am J Med 1984;76:398–404.

    Google Scholar 

  39. Roubidoux MA, Dunnick NR, Klotmann PE, Newman GE, Coman RH, Kadir S, Svetkey LP. Renal vein renins: inability to predict response to revascularization in patients with hypertension. Radiology 1991;178:819–822.

    Google Scholar 

  40. Re R, Novelline R, Escourrou MT, Athanasoulis C, Burton J, Haber E. Inhibition of angiotensin-converting enzyme for diagnosis of renal artery stenosis. N Engl J Med 1978;298:582–586.

    Google Scholar 

  41. Lyons DF, Streck WF, Kem DC, Brown RD, Galloway DC, Williams GR, Chrysant SG, Danisa K, Carollo M. Captopril stimulation of differential renins in renovascular hypertension. Hypertension 1983;5:615–622.

    Google Scholar 

  42. Staessen J, Wilms G, Baert A, Fagard R, Lijnen P, Suy R, Amery A. Blood pressure during long-term converting-enzyme inhibition predicts the curability of renovascular hypertension by angioplasty. Am J Hypertens 1988;1:208–214.

    Google Scholar 

  43. Mann SJ, Pickering TG, Sos TA, Uzzo RG, Salil Sarkar BA, Friend K, Rackson ME, Laragh JH. Captopril renography in the diagnosis of renal artery stenosis; accuracy and limitations. Am J Med 1991;90:30–40.

    Google Scholar 

  44. Postma CT,Van Oijen AH, Barentz JO, De Boo T, Hoefnagels WH, Cortens FH, Thien T. The value of tests predicting renovascular hypertension in patients with renal artery stenosis treated by angioplasty. Arch Intern Med 1991;151:1531–1535.

    Google Scholar 

  45. Bardelli M, Jensen G, Volkmann R, Aurell M. Non-invasive ultrasound assessment of renal artery stenosis by means of the Gosling pulsatility index. J Hypertens 1992;10:985–989.

    Google Scholar 

  46. Madj M, Potter BM, Guzetta PC, Ruley EJ. Effect of captopril on efficacy of renal scintigraphy in detection of renal artery stenosis [abstract]. J Nucl Med 1983;24:23.

    Google Scholar 

  47. Fommei E, Ghione S, Palla L, Mosca F, Ferrari M, Palombo C, Giaconi S, Gazetti P, Donato L. Renal scintigraphic captopril test in the diagnosis of renovascular hypertension. Hypertension 1987;10:212–220.

    Google Scholar 

  48. Dondi M, Franchi R, Levorato M, Zuccala A, Gaggi R, Mirelli M, Stella A, Marchetta F, Losinno F, Monetti N. Evaluation of hypertensive patients by means of captopril enhanced renal scintigraphy with technetium-99m DTPA. J Nucl Med 1989;30:615–621.

    Google Scholar 

  49. Chen CC, Hoffer PR, Vahjen G, Gottschalk A, Koster K, Zubal G, Setaro JF, Roer DA, Black HR. Patients with high risk for renal artery stenosis: a simple method of renal scintigraphic analysis with Tc-99m DTPA and captopril. Radiology 1990;176:365–370.

    Google Scholar 

  50. Svetkey LP, Wilkinson R Jr, Dunnick NR, Smith SR, Dunham CB, Lambert M, Klotman PE. Captopril renography in the diagnosis of renovascular disease. Am J Hypertens 1991;4:S711-S715.

    Google Scholar 

  51. Setaro JF, Chen CC, Hoffer PB, Black HR. Captopril renography in the diagnosis of renal artery stenosis and prediction of improvement with revascularization. J Hypertens 1991;4:S698-S705.

    Google Scholar 

  52. MacLean AG, Hilson AJW, Scoble JE, Maher ER, Thakrar DS, Moorhead JF, Sweny P. Screening for renovascular disease with captopril-enhanced renography. Nephrol Dial Transplant 1992;7:211–215.

    Google Scholar 

  53. Fommei E, Ghione S, Hilson AJW, Mezzalma L, Oei HY, Piepsz A, Volterrani D, and the Group. European multicentre study: captopril radionuclide test in renovascular hypertension. Communication at the 8th International Symposium on Radionuclides in Nephrourology, Chester, May 1992 [abstract]. Nucl Med Commun 1992;13:370.

    Google Scholar 

  54. Pedersen EB, Jensen FT, Madsen B, Eiskjaer H, Nielsen JT, Rehling M, Angiotensin-converting enzyme inhibitor renography in the diagnosis of renovascular hypertension. Studies before and after angioplas Nephrol Dial Transplant1992;7:1178–1184.

    Google Scholar 

  55. Geyskes GG, Oci HY, Puylaert BAJ, Dorhout Mees EJ. Renovascular hypertension identified by captopril-induced changes in the renogram. Hypertension 1987;9:451–458.

    Google Scholar 

  56. Sfakianakis GN, Bourgoignie JJ, Jaffe D, Kryiakides G, Perez-stable E, Duncan RC. Single-dose captopril scintigraphy in the diagnosis of renovascular hypertension. J Nucl Med 1987;28:1383–1392.

    Google Scholar 

  57. Dondi M, Fanti S, De Fabritiis A, Zuccala A, Gaggi R, Mirelli M, Stella A, Marengo M, Losinno F, Monetti N. Prognostic value of captopril renal scintigraphy in renovascular hypertension. J Nucl Med 1992;33:2040–2044.

    Google Scholar 

  58. Kahn D, Meis DM, Kirchner PD. Captopril enhanced renal scintigraphy (CERS) using technetium-99m MAG3 in renal artery stenosis (RAS) and renovascular hypertension [abstract]. J Nucl Med 1991;32:934.

    Google Scholar 

  59. Lepage R, Lemieux RJ, Cartier P, Charlebois N, McNamara D. Pre-post captopril Tc-99m MAG3 renography: correlation with renal angiography and plasma renin-activity [abstract]. J Nucl Med 1991;32:934.

    Google Scholar 

  60. Nitzsche E, Blum W, Rump E, Keller E, Moser E. Captopril renography (CR) as a noninvasive test for hypertension secondary to renal artery stenosis (RAS) [abstract]. J Nucl Med 1991;32:1107.

    Google Scholar 

  61. Tiel-van Buul AV, Van Muntfrans GA, Reekers JA, Van Dongen AV, Oei HY, Van Royen EA. Renovascular hypertension: captopril renal scintigraphy versus the captopril (plasma renin activity) test [abstract]. J Nucl Med 1992;33:907.

    Google Scholar 

  62. Erbslöh-Mö1ler B, Dumas A, Roth D, Sfakianakis GN, Bourgoignie JJ. Furosemide 131 I-hippuran renography after angiotensin-converting enzyme inhibition for the diagnosis of renovascular hypertension. Am J Med 1991;90:23–29.

    Google Scholar 

  63. Geyskes GG, De Bruyn AJG. Captopril renography and the effect of percutaneous transluminal angioplasty on blood pressure in 94 patients with renal artery stenosis. Am J Hypertens 1991;4:S685-S689.

    Google Scholar 

  64. Wenting GJ, Tan-tjiong HL, Derkx FH, De Bruyn JHB, Man In't Veld AJ, Schalekamp MADH. Split renal function after captopril in unilateral renal artery stenosis. Br Med J 1984;288:886–890.

    Google Scholar 

  65. De Zeeuw D, Jonker GJ, Kremer Hovinga TK, Beekhuis H, Piers DA, Huisman RM, De Jong PE. The mechanism and diagnostic value of angiotensin I converting enzyme inhibition renography. Am J Hypertens 1991;4:S741-S744.

    Google Scholar 

  66. Conrad GR, Wesolowski CA, Berbaum KS, Jensen KC, Kirchner PT. Renal arteriovenous transit times of technetium-radiolabeled chelates. J Nucl Med 1987;28:1134–1143.

    Google Scholar 

  67. Ishibashi M, Morita S, Umezaki N, Ohtake M. Evaluation of renal first pass blood flow with a functional image technique in hypertensive patients. Eur J Nucl Med 1988;14:25–27.

    Google Scholar 

  68. Peters AM, Crossman BD, Brady AJ, Hemingway AP, Roddie ME, Allison DJ. Noninvasive measurement of renal blood flow with technetium-99m-DTPA in the evaluation of patients with suspected renovascular hypertension. J Nucl Med 1990;31:1980–1985.

    Google Scholar 

  69. Morton KA, Rose SC, Haakenstad AO, Handy JE, Scuderi AJ, Datz FL. Diagnostic use of angiotensin converting enzyme (ACE)-inhibited renal scintigraphy in the identification of selective renal artery stenosis in the presence of multiple renal arteries: a case report. J Nucl Med 1990;31:1847–1850.

    Google Scholar 

  70. Simon TR, Cuocolo A, Sandbrock D, Miller D. Renal scintigraphy in renovascular hypertension secondary to stenosis of a supplemental renal artery. J Nucl Med 1990;31:674–678.

    Google Scholar 

  71. Kim CK, Palestro CJ, Goldsmith SJ. Simple visual criteria for (+) captopril renal scintigraphy [abstract]. J Nucl Med 1991;32:933.

    Google Scholar 

  72. Oei HY, Hoogeven EK, Derkx FHM, Pieterman AH, Van Den Meiracker AH, Man In't Veld AJ, Shalekamp MADH, Krenning EP. Tc-99m MAG3 scintigraphy with captopril for detection of renal artery stenosis (RAS) [abstract]. J Nucl Med 1992;33:990.

    Google Scholar 

  73. Gruenewald SM, Collins LT, Antico VF, Farlow DC, Fawdry RM. Can quantitative renography predict the outcome of treatment of atherosclerotic renal artery stenosis? J Nucl Med 1989:30:1946–1954.

    Google Scholar 

  74. Stabin M, Taylor A Jr, Eshida D, Wooter W. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA and iodine-131–01H based on human biodistribution studies. J Nucl Med 1992;33:33–40.

    Google Scholar 

  75. Kremer Hovinga TK, De Jong PE, Piers DA, Beekhuis H, Van Der Hem GK, De Zeeuw D. Diagnostic use of angiotensin converting enzyme inhibitors in radioisotope evaluation of unilateral renal artery stenosis. J Nucl Med 1989;30:605–614.

    Google Scholar 

  76. McAfee JG, Kopecky RT, Deaver Thomas F, Hellwig B, Roskopf M. Comparison of different radioactive agents for the detection of renovascular hypertension with captopril in a rat model. J Nucl Med 1988;29:509–515.

    Google Scholar 

  77. Bajnok L, Varga J, Kurta G. Technetium-99m diethylene triamine penta-acetic acid and dimercaptosuccinic acid in the detection of a segmental branch stenosis of the renal artery by captopril renography. Eur J Nucl Med 1992;19:62–64.

    Google Scholar 

  78. Oei YH. Captopril renography. Early observations and diagnostic criteria. Am J Hypertens 1991;4:S678-S684.

    Google Scholar 

  79. Goldfarb DA, Satoh S, Fergagny AF, Stowe NT, Nally JV, Antar MA, Ferrario CM, Novick AC. Assessment of chronic renal ischaemia and its reversibility using Tc99m-MAG3 (MAG3R) [abstract]. Nucl Med Commun 1992:13:371.

    Google Scholar 

  80. La Pidus AS, Owens DS, Fajman WA, Lund EC, Jones ME, Ziffer JA. The association of renovascular disease with asymmetric renal uptake on adenosine thallium scintigraphy [abstract]. J Nucl Med 1991;32:1104.

    Google Scholar 

  81. Hurwitz GA, Powe JE, Mattar AG, Reid RH, Driedger AA, Rendak I, Hogendoorn P. Differential renal uptake of 201Tl: requirements for acquisition, display and quantification. Nucl Med Commun 1991;12:885–899.

    Google Scholar 

  82. Hurwitz GA, Bhargava R, Scwab ME, Mattar AG, Zabel PL, Hogendoorn P, Morrissey GJ. Dynamic renal imaging with technetium-99m MIBI: potential for assessment of renovascular disorders [abstract]. J Nucl Med 1988;29:2027.

    Google Scholar 

  83. Kopecky RT, Deaver Thomas F, McAfee JG. Furosemide augments the effects of captopril on nuclear studies in renovascular stenosis. Hypertension 1987;10:181–188.

    Google Scholar 

  84. Deaver Thomas F, Kopecky RT, McAfee JG, Anderson GH, Weigle JB. The effects of volume depletion on captopril renography [abstract]. J Nucl Med 1988;29:849.

    Google Scholar 

  85. Lee HB, Blaufox MD. Renal functional response to captopril during diuretic therapy. J Nucl Med 1992;33:739–743.

    Google Scholar 

  86. Ljungman S, Granerus G. The evaluation of kidney function. in hypertensive patients. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis, and management. New York: Raven; 1990:1493–1507.

    Google Scholar 

  87. Jensen G, Moonen M, Volkmann R, Aurell M. Reliability of CEI-enhanced 99m-Tc-DTPA gamma camera renography in the detection of renovascular hypertension [abstract]. Nucl Med Commun 1992;13:370.

    Google Scholar 

  88. Emond C, Bascands JL, Rakotoarivony J, Praddaude F, Bompart G, Pecher C, Ader JL, Girolami JP. Glomerular B2-kinin-binding sites in two-kidney, one-clip hypertensive rats. Am J Physiol 1991;260:F626-F634.

    Google Scholar 

  89. Mattson DL, Roman RJ. Role of kinins and angiotensin II in the renal hemodyamic response to captopril. Am J Physiol 1991;260:F670-F679.

    Google Scholar 

  90. Lee HB, Blaufox MD. Renal effects of DUP 753 in renovascular hypertension [abstract]. J Nucl Med 1991;32:1103.

    Google Scholar 

  91. Hirsch H, Fisher RA, Banks RO, Huth CJ, Alspaugh JP, Maxon HR III. Use of the peripheral vascular dopamine receptor (DA-1) agonist Fenoldopam (FD) in the diagnosis of renal artery stenosis (RAS). Results in a 1 clip-2 kidney dog model [abstract]. J Nucl Med 1991;32:933.

    Google Scholar 

  92. Blaufox MD, Fine EJ. Role of nuclear medicine techniques for evaluating hypertensive disease. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis and management. New York: Raven; 1990:1509–1534.

    Google Scholar 

  93. Hupp T, Clorius JH, Allenberg JR. Renovascular hypertension: predicting surgical cure with exercise renography. J Vase Surg 1991;14:200–207.

    Google Scholar 

  94. Clorius JH, Schmidlin P. The exercise renogram. A new approach documents renal involvement in systemic hypertension. J Nucl Med 1983;24:104–109.

    Google Scholar 

  95. Clorius JH, Mann J, Schmidlin P, Strauss LG, Saur T, Irngartinger G. Clinical evaluation of patients with hypertension and exercise-induced renal dysfunction. Hypertension 1987;10:287–293.

    Google Scholar 

  96. Clorius JH, Reinbold F, Hupp T, Mandelbaum A, Schmidlin P, Van Haick G. Renovascular hypertension: a perfusion disturbance that escaped recognition. J Nucl Med 1993;34:4856.

    Google Scholar 

  97. Miziuiri S, Hayashi I, Ohara T, Hirata K, Sasaki Y. Exercise induced renal dysfunction demonstrated both in hypertensives and normotensive controls studies by Tc99m-DTPA [abstract]. J Nucl Med 1985;26:P133.

    Google Scholar 

  98. Fine EJ, Blaufox MD. The Einstein/Cornell collaborative protocol to assess efficacy and methodology in captopril scintirenography. Early results in patients with essential hypertension. Am J Hypertens 1991;4:S716-S720.

    Google Scholar 

  99. Wesolowski G, Conrad G, Kirchner PT, Meng RL, Jensen KC. Differential first transit technetium-99m recordings for predicting renovascular disease [abstract]. J Nucl Med 1985;26:674.

    Google Scholar 

  100. Nally JV, Chen C, Fine EJ, Fommei E, Ghione S, Geyskes GG, Hoffer PB, Sfakianakis G. Diagnosis criteria of renovascular hypertension with captopril renography. A consensus statement. Am J Hypertens 1991;4:S749-S752.

    Google Scholar 

  101. Rocatello D, Piciotto G, Rabbia C, Pozzato M, De Philippi PG, Piccoli G. Prospective study on captopril renography in hypertensive patients. Am J Nephrol 1992;12:406–411.

    Google Scholar 

  102. Kletter K, Leitha T, Dudczack R. Diagnostic value of captopril renography (CRG) in patients with bilateral renal artery stenosis (RAS) [abstract]. Eur JNucl Med 1990;16:417.

    Google Scholar 

  103. Licho R, Kershaw G. Captopril-stimulated PRA: an adjunct to captopril renography in bilateral renal artery stenosis (RAS) [abstract]. J Nucl Med 1992;33:907.

    Google Scholar 

  104. Itoh K, Shinohara M, Togashi M, Koyanagi T. Captopril renal scintigraphy in a patient with bilateral renal artery stenosis. J Nucl Med 1989;30:2042–2045.

    Google Scholar 

  105. Ingelfinger JR. Renovascular disease in children. Kidney Int 1993;43:493–505.

    PubMed  Google Scholar 

  106. Curtis JJ. Hypertension and kidney transplantation. Curr Opin Nephrol Hypertens 1992;1:100–105.

    Google Scholar 

  107. Dubovsky EV, Russell CD. Diagnosis of renovascular hypertension after renal transplantation. Am J Hypertens 1991;4:S724-S730.

    Google Scholar 

  108. Dubovsky EV, Russell CD, Diethelm AG, Curtis JJ, Julian BA, Gaston RJ. Captopril testing for renal graft artery stenosis [abstract]. Nucl Med Commun 1992;13:371.

    Google Scholar 

  109. Murray BM, Venuto RC, Kohli R, Cunningham EE. Enalapril-associated acute renal failure in renal transplants: possible role of cyclosporine. Am J Kidney Dis 1990;16:66–69.

    Google Scholar 

  110. Gosse P, Dupas JY, Reynaud P, Jullien E, Dallocchi M. Captopril test in the detection of renovascular hypertension in a population with low prevalence of the disease. A prospective study. Am J Hypertens 1989;2:191–193.

    Google Scholar 

  111. Postma CT, Van Der Steen PH, Hoefnagels WH, De Boo T, Thien T. The captopril test in the detection of renovascular disease in hypertensive patients. Arch Intern Med 1990;150:625–628.

    Google Scholar 

  112. Hansen PB, Garsdal P, Fruergaard P. The captopril test for identification of renovascular hypertension: value and immediate adverse effects. J Intern Med 1990;228:159–163.

    Google Scholar 

  113. Frederickson ED, Wilcox CS, Bucci CM, Loon NR, Peterson JC, Brown NL, Thompson RD, Smith TB, Wingo CS. A prospective evaluation of a simplified captopril test for the detection of renovascular hypertension. Arch Intern Med 1990;150:569–572.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d'Explorations Fonctionnelles et de Medecine Nucleaire, Hôpital Broussais, 96 rue Didot, F-75674, Paris Cédex 14, France

    Alain Prigent

Authors
  1. Alain Prigent
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This review is based on the themes developed in a lecture given by the author at the European Association of Nuclear Medicine Congress in Lisbon on 25 August 1992

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prigent, A. The diagnosis of renovascular hypertension: the role of captopril renal scintigraphy and related issues. Eur J Nucl Med 20, 625–644 (1993). https://doi.org/10.1007/BF00176560

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00176560

Key words

Search

Navigation